| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/04/2008 | CN100391513C Medicinal preparation for treating cardio and cerebral vascular disease and its preparation method and quality control method |
| 06/04/2008 | CN100391511C Peach kernel macrostem onion powder |
| 06/04/2008 | CN100391510C Chinese-medicinal preparation for gastroin testinal function and its making method |
| 06/04/2008 | CN100391508C Medicine for auxiliary treating deficiency of both the splenic and pulmonary Qi alopecia |
| 06/04/2008 | CN100391507C Method of preparing medicine for treating condyloma acuminatum |
| 06/04/2008 | CN100391505C Medicine for treating esophagus cancer and cardia cancer and its preparation method |
| 06/04/2008 | CN100391504C Pharmaceutical composition for treating sexual disorder and its preparation process |
| 06/04/2008 | CN100391503C Use of Chinese and Western medicine composition in preparing medicine for preventing and treating xeroma |
| 06/04/2008 | CN100391501C Medicinal wine for stabilizing blood pressure |
| 06/04/2008 | CN100391500C Chinese medicine preparation for treating wind-heat syndrome of acute pharyngitis and its preparation process |
| 06/04/2008 | CN100391499C Chewing gum for radiation protection |
| 06/04/2008 | CN100391498C Essential oil of 'Shiquan Dabu Wan', namely beta-cyclodextrin inclusion compound and its preparation process |
| 06/04/2008 | CN100391494C Compound chinese preparation for treating pain symptom and its preparing process |
| 06/04/2008 | CN100391491C Medicine composition for treating cardiovascular diseases and preparation method thereof |
| 06/04/2008 | CN100391488C Chinese medicinal health product |
| 06/04/2008 | CN100391487C Preparation for treating leukopenia and its preparation method |
| 06/04/2008 | CN100391485C Medicine for treating diabetes and its preparation method |
| 06/04/2008 | CN100391484C Medicine for treating cardio-cerebrovascular disease |
| 06/04/2008 | CN100391483C Lonicera hypoglauca Miq stem-leaf extract, its medicine use and medicine composition |
| 06/04/2008 | CN100391482C Saussurea involucrate powder injection |
| 06/04/2008 | CN100391481C American ginseng soft capsule |
| 06/04/2008 | CN100391480C Hydrophilic gel pleximetric paste and its preparation method |
| 06/04/2008 | CN100391479C Wound protecting and treating smearing preparation |
| 06/04/2008 | CN100391478C Extracte of Aspongopus chinensis Dallas and Extraction method therefor medicinal use and preparation thereof |
| 06/04/2008 | CN100391476C Medicine composition for delaying senility and raising immunity and its preparation method |
| 06/04/2008 | CN100391474C Injection medicine for treating platelet abatement |
| 06/04/2008 | CN100391468C Protopanaxadiol lyophilized agent and its preparing method |
| 06/04/2008 | CN100391467C Nano emulsion of containing ginsenoside, preparation method and usage |
| 06/04/2008 | CN100391464C Pharmaceutical compositions comprising active vitamin D compounds |
| 06/04/2008 | CN100391463C Cyclovirobuxine dripping pill and its preparation process |
| 06/04/2008 | CN100391462C Enhanced drug delivery in transdermal systems |
| 06/04/2008 | CN100391459C Doxazosin mesilate slow releasing preparation |
| 06/04/2008 | CN100391458C Preparation method of ziprasidone or its salt inclusion |
| 06/04/2008 | CN100391457C Novel bulleyaconitine A powder injection |
| 06/04/2008 | CN100391454C Preparation of hydrobromic acid dextro methaphen and beta cyclodeatrin compounding object |
| 06/04/2008 | CN100391452C Red sage root preparation for injection and its preparation method |
| 06/04/2008 | CN100391450C Compound medicine composition and its preparation and use |
| 06/04/2008 | CN100391447C Freeze dried powder injection of coenzyme Q10 and its preparation process |
| 06/04/2008 | CN100391445C Novel 'burst-free' sustained release poly-(lactide/glycolide) mi crospheres |
| 06/04/2008 | CN100391444C Mammary aggregation elimination capsule and its preparation method |
| 06/04/2008 | CN100391443C Ginseng-monkshood slow-release coating skeleton piller for treating qi asthenia and yang depletion and preparing method thereof |
| 06/04/2008 | CN100391442C Ginseng-monkshood slow-release coating preparation film controlled piller for treating qi asthenia and yang depletion and preparing method thereof |
| 06/04/2008 | CN100391441C Matrine elaioplast drop ball and its preparation method |
| 06/04/2008 | CN100391440C Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base |
| 06/04/2008 | CN100391439C Immunopotentiators |
| 06/04/2008 | CN100391438C Process for making aqueous coated beadlets |
| 06/04/2008 | CN100391437C GM-CSF targeted medicine liposome for resisting acute myelogenous leukemia and preparation method thereof |
| 06/04/2008 | CN100391436C Ginseng and aconite oral liquid for treating qi vacuity and yang desertion and its preparation method |
| 06/04/2008 | CN100391433C Carotenoid composition and method for protecting skin |
| 06/04/2008 | CN100391430C Health care towel for health of feet |
| 06/03/2008 | US7381976 Monochromatic fluid treatment systems |
| 06/03/2008 | US7381807 Of given nucleotide sequence; encapsulated in slow release delivery vehicle; includes viral or bacterial antigen; increases cell proliferation, differentiation, cytokine and antibody production for lymphocytes |
| 06/03/2008 | US7381796 Dried blood factor composition comprising trehalose |
| 06/03/2008 | US7381430 Prepared from Geranium, Root of Membranous Milkvetch, Herba Solani Nigri, Honeysuckle Flower, Flower of Common Bombax, Fruit of Belleric Terminalia, Herba Hedyotis Diffusae, Pomegranate Rind, Radix Oryzae, and Fructus Trapae; treating Acquired Immune Deficiency Syndrome |
| 06/03/2008 | US7381428 Stabilized lanthanum carbonate compositions |
| 06/03/2008 | US7381426 Therapy for bone disorders |
| 06/03/2008 | US7381425 Preservation of bioactive materials by freeze dried foam |
| 06/03/2008 | US7381424 Hydrostatic delivery system for controlled delivery of agent |
| 06/03/2008 | US7381423 Use of nanodispersions in cosmetic end formulations |
| 06/03/2008 | US7381422 Mixing cationic surfactant, a polyoxyethylene and polyoxypropylene block copolymer and a polynucleotide at a temperature below the cloud point of said block copolymer to form a mixture; cold filtering the mixture to produce a sterile formulation |
| 06/03/2008 | US7381421 Liposomes |
| 06/03/2008 | US7381419 Medical composition kit for treating lesioned abnormal tissue |
| 06/03/2008 | US7381418 Methylene-containing copolymer of an unsaturated hydrocarbon monomer such as alpha-olefin, diolefin or cyclic olefin and an acrylic or vinyl monomer or having polyether, polylactone or polyester units; crosslinked with a radiation dose of at least 10,000 rads |
| 06/03/2008 | US7381417 Fragrance delivery system for surface cleaners and conditioners |
| 06/03/2008 | US7381404 Treatment for dry macular degeneration |
| 06/03/2008 | US7381402 Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
| 06/03/2008 | US7381262 Method of preparing porous calcium phosphate granules |
| 06/03/2008 | CA2536069C Use of green porphyrins in ocular diagnosis and therapy |
| 06/03/2008 | CA2501587C Solid preparation having phase containing insulin sensitizer and another active ingredient uniformly mixed |
| 06/03/2008 | CA2382294C Use of docetaxel for treating hepatocellular carcinoma |
| 06/03/2008 | CA2350430C Method and apparatus for liposome production |
| 06/03/2008 | CA2346016C Glucoside paucilamellar vesicles |
| 06/03/2008 | CA2345077C A method for producing a layered product |
| 06/03/2008 | CA2335065C Pharmaceutical formulations for aerosols with two or more active substances |
| 06/03/2008 | CA2326356C Oral liquid antidepressant solution |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/03/2008 | CA2256118C Animal feed pelleting process and animal feed pellets produced therefrom |
| 06/03/2008 | CA2228610C Controlled release products |
| 06/03/2008 | CA2227004C Sunscreen compositions |
| 06/03/2008 | CA2201725C Composition, device and method for electrotransport agent delivery |
| 06/03/2008 | CA2178144C Stabilized aqueous liquid preparations of blood coagulation factor xiii |
| 06/03/2008 | CA2122596C Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 05/29/2008 | WO2008064338A2 Valsartan formulation for pulsatile delivery |
| 05/29/2008 | WO2008064202A2 Modified-release formulations of calcium receptor-active compounds |
| 05/29/2008 | WO2008064192A2 Modified release analgesic suspensions |
| 05/29/2008 | WO2008063766A2 Amorphous ezetimibe and the production thereof |
| 05/29/2008 | WO2008063634A1 Stable parenteral formulation containing a rsv inhibitor of a benzodiazepine structure |
| 05/29/2008 | WO2008063581A2 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| 05/29/2008 | WO2008063356A2 Suture-specific coatings for modulated release of biocative agents |
| 05/29/2008 | WO2008063341A2 Dual action, inhaled formulations providing both an immediate and sustained release profile |
| 05/29/2008 | WO2008063323A2 Treatment with antiarrhythmics and omega-3 fatty acids and a combination product thereof |
| 05/29/2008 | WO2008063229A2 Enzymatic debridement therapy for abnormal cell proliferation |
| 05/29/2008 | WO2008063158A2 Method for nanoencapsulation |
| 05/29/2008 | WO2008062908A1 Method for producing particles and particles |
| 05/29/2008 | WO2008062481A2 Formulations of peg-interferon alpha conjugates |
| 05/29/2008 | WO2008062475A2 Pharmaceutical compositions of ursodiol |
| 05/29/2008 | WO2008062470A2 Stabilized controlled release dosage form of gliclazide |
| 05/29/2008 | WO2008062440A2 Programmable buoyant delivery technology |
| 05/29/2008 | WO2008062437A2 Process for the preparation of sevelamer hydrochloride and formulation thereof |
| 05/29/2008 | WO2008062435A2 Stabilised dosage forms of amlodipine besylate |